Presentation Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS Presenter: Andr?s Kom?csi October 01, 2012 REGISTER for free or LOG IN to view this content ACS/AMI Prevention CAD Pharma Clinical Pharma Factoid Up Next Presentation Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib Presenter: Renato D. Lopes October 03, 2012 More slides + Presentation TCT 2012 Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future! Presenter: Jean-Fran?ois Tanguay October 23, 2012 Presentation TCT 2012 Surgery Is the Obvious Choice! Presenter: Steven Bolling October 23, 2012 We Recommend
Presentation Efficacy and Safety of Apixaban vs. Warfarin Based on Patient Risk of Stroke and Bleeding in A-fib Presenter: Renato D. Lopes October 03, 2012
Presentation TCT 2012 Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future! Presenter: Jean-Fran?ois Tanguay October 23, 2012